BeStock  

Sophia Genetics SOPH

US equityMarket cap rank #3613Health Information Services
$7.15 −$0.23 (-3.12%)
Market closed · Oct 8, 7:00 am ET · Last extended-hours $7.15 0.00%
Open$7.26
Prev close$7.38
Day range$7.08 – $7.37
Volume432.8K
Market cap$608.66M
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

Technical signals

Trend readLeaning bearish

2 bullish · 4 bearish of 7 signals

IndicatorValueSignalReading
Price vs 20-day average-11.2%BearishTrading below the 20-day average of $8.05
Price vs 50-day average-8.3%BearishTrading below the 50-day average of $7.80
Price vs 200-day average+24.5%BullishTrading above the 200-day average of $5.74
50-day vs 200-day50d above 200dBullishThe 50-day average is above the 200-day average
RSI (14)36.4BearishMomentum leans negative
MACD (12,26,9)-0.04BearishMACD line is below its signal line
Bollinger band position-14%NeutralBelow the lower band, an extended move

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

Levels & volatility

Moving averages

AverageLevelPrice vs. it
20-day SMA$8.05-11.2%
50-day SMA$7.80-8.3%
200-day SMA$5.74+24.5%

Recent price levels

LevelPrice
20-day high$8.73
20-day low$7.08
60-day high$8.98
60-day low$5.42
Upper Bollinger band$8.75
Lower Bollinger band$7.35

The 50-day average is currently 35.8% above the 200-day average — consistent with a “golden cross” (bullish) configuration.

30-day volatility61.4%
Average true range6.87% of price
Max drawdown (1y)-25.7%
Volume (10d vs 90d)1.30x

Discussion

No comments yet — be the first to weigh in on SOPH.

Leave a comment

Scroll to Top